Pfizer’s Covid Booster Shot for Younger Teens Wins FDA Clearance, Stock Drops (But Pfizer Underperformed S&P 500 Index Since Fed COVID Stimulus)

Sharing is Caring!

by confoundedinterest17

You would think that an FDA approval to give booster shots to millions of new patients would send their stock soaring. It didn’t Pfizer dropped along with the S&P 500 index.

See also  A Market Veteran Is Warning About A January Stock Market Crash

Despite the growth of COVID cases in the US (blue dashed line), Pfizer stock has only gone up by “only” 88% since March 2020. The S&P 500 index rose by 100%.

See also  Rents in NYC Exceeding Pre-COVID Levels

I under what Pfizer’s performance would be if The Fed wasn’t blowing a hurricane wind at the back of the market.




Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.